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Background: Helicobacter pylori are successful colonizers of the human gastric mucosa. Colonization increases the
risk of peptic ulcer disease and adenocarcinoma. However, potential benefits of H. pylori colonization include
protection against early-onset asthma and against gastrointestinal infections. Campylobacter jejuni are a leading
cause of bacterial diarrhea and complications include Guillain-Barré syndrome. Here, we describe the development
of reliable serological assays to detect antibodies against those two bacteria in Rhesus macaques and investigated
their distribution within a social group of monkeys.
Methods: Two cohorts of monkeys were analyzed. The first cohort consisted of 30 monkeys and was used to
establish an enzyme-linked immunosorbent assay (ELISA) for H. pylori antibodies detection. To evaluate colonization
of those macaques, stomach biopsies were collected and analyzed for the presence of H. pylori by histology and
culture. C. jejuni ELISAs were established using human serum with known C. jejuni antibody status. Next, plasma
samples of the 89 macaques (Cohort 2) were assayed for antibodies and then statistically analyzed.
Results: An H. pylori IgG ELISA, which was 100% specific and 93% sensitive, was established. In contrast, the IgA ELISA
was only 82% specific and 61% sensitive. The CagA IgG assay was 100% sensitive and 61% of the macaques were
positive. In cohort 2, 62% macaques were H. pylori sero-positive and 52% were CagA positive. The prevalence of H. pylori
IgG and CagA IgG increased with monkey age as described for humans. Of the 89 macaques 52% showed IgG against C.
jejuni but in contrast to H. pylori, the sero-prevalence was not associated with increasing age. However, there was a drop
in the IgG (but not in IgA) mean values between infant and juvenile macaques, similar to trends described in humans.
Conclusions: Rhesus macaques have widespread exposure to H. pylori and C. jejuni, reflecting their social conditions and
implying that Rhesus macaques might provide a model to study effects of these two important human mucosal bacteria
on a population.
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Helicobacter pylori are Gram-negative bacteria that
colonize the gastric mucosa of humans across the world.
However, H. pylori is disappearing from populations in
developed countries [1,2]. In developing countries, up to
90% of the adult population carries the organism [3,4].
H. pylori is acquired early in life [5,6] and generally per-
sists unless hosts are treated with antibiotics [1]. Gastric* Correspondence: sabine.kienesberger@nyumc.org
1Department of Medicine, NYU Langone Medical Center, New York, NY, USA
Full list of author information is available at the end of the article
© 2012 Kienesberger et al.; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumH. pylori colonization increases risk of peptic ulcer dis-
ease as well as adenocarcinoma of the distal stomach [7].
In addition to negative effects late in life, there is now
evidence that H. pylori may protect against early-onset
asthma [8-10] and gastrointestinal infections [11-13],
thus providing benefits early in life. Because Rhesus
macaques usually are persistently colonized with H. pyl-
ori and develop chronic gastritis [13,14], they represent
a model to study host interactions.
Campylobacter jejuni are Gram-negative bacteria that
are among the leading causes of acute gastroenteritisentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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clude the Guillain–Barré syndrome and reactive arthritis
[16-18]. C. jejuni infections are known to be highly
prevalent within monkey colonies, especially when the
animals are living under non-natural conditions [19].
Despite recent advances [20-24], the colonization dy-
namics of H. pylori and C. jejuni in macaques in relation
to infection in humans have been little examined. The
purpose of this study was to (I) establish reliable sero-
logical assays to detect monkey antibodies to H. pylori-
and C. jejuni-specific antigens and (II) to investigate the
sero-prevalence of H. pylori and C. jejuni in a social-
group of Rhesus macaques. We hypothesized that a
group of monkeys with constant contact with each other
would be manifested by a high prevalence of responses
to these enteric organisms, similar to those shown by
humans before the introduction of antibiotics and better
hygienic standards. Such assays could provide models to
study H. pylori spread, eradication, and putative positive
and negative effects in individuals and in populations.
Results
Verification of ELISA for determination of H. pylori
sero-status using Rhesus macaque Cohort 1
Cohort 1 was used to establish reliable cut-off values for
H. pylori sero-positivity to analyze Cohort 2. According
to endoscopy performed on the 30 animals in Cohort 1,
13 macaques were negative for H. pylori and 17 were
positive. Specific plasma IgG to H. pylori was substan-
tially higher in animals who had been shown by endos-
copy to be colonized compared to negative macaques
(Table 1). Having a positive IgG antibody (ODR >0.340)
determination was 100% sensitive but it was only 70%
specific for colonization when endoscopy was used
as the gold standard (Table 2). Because of presumed
falsely negative endoscopic results observed in the initial
samples, we defined H. pylori-positivity by either a posi-
tive endoscopy or IgG ODR >0.340 on the initial plasma.
When we tested these combined criteria for 40 follow-
up plasma obtained from the same animals, we found
that this combination was highly accurate (93% sensitive,
100% specific). Four macaques were H. pylori biopsy-
negative on the initial examination but had high CagA,
IgG, and IgA values as well as high gastric inflammation
scores (Table 1). The CagA assay was highly specific
(100%) and 61% of the H. pylori-positive macaques were
CagA-positive, which is similar to the prevalence in
humans [25-27]. In contrast, the IgA ELISA was only
82% specific and 61% sensitive (Table 2). In total, we
conclude that determination of the H. pylori IgG status
is highly accurate in Rhesus macaques, reflecting the
actual H. pylori colonization status. As such, we could
use it to assess H. pylori status in monkeys without
endoscopy.Cohort 2: Sero-prevalence of H. pylori is higher in older
Rhesus macaques
First, we examined the ODR-values obtained for the Co-
hort 2 monkeys. Since the cut-offs obtained from the
Cohort 1 macaques and from Cohort 2 were very similar
(Table 3), we considered them to be reliable. We then
examined the H. pylori IgG status in 89 macaques in Co-
hort 2, using the determined cut-off. Summaries of the
data are shown in Table 4 and Figure 1. A total of 58
(62%) of the 89 Rhesus macaques were H. pylori sero-
positive and the sero-prevalence of H. pylori increased
with age (Cochran-Armitage Trend Test, p < 0.0001).
H. pylori IgA status correlates with the IgG status only in
older Rhesus macaques
The serum of the 89 animals was also tested for the
presence of serum IgA antibodies to H. pylori antigens
using the IgG-determined status as a standard. An IgA
cut-off at 0.39 was considered predictive to determine
the H. pylori status since it yielded the same percent
(64%) of positivity. Of the 57 macaques determined to
be IgA-positive (Figure 1), in the youngest group, only 2
(7%) monkeys were both IgA and IgG positive, but 9
(38%) group 2 monkeys, 14 (67%) group 3 monkeys and
14 (82%) monkeys of the oldest group showed double-
positive status (Figure 1). Thus, IgG antibodies become
more prevalent with age in the H. pylori-positive
monkeys.
CagA sero-prevalence correlates with H. pylori IgG status
When the Rhesus macaques of Cohort 2 were analyzed
with the CagA cut-off established at 0.200, 52% of the
macaques were CagA+, similar to the 61% of CagA+
monkeys of Cohort 1. As with the H. pylori IgG, the
prevalence of CagA antibodies increased with the age of
the monkeys (Table 4 and Figure 1) (Cochran-Armitage
Trend Test, p < 0.0001). With the exception of the
youngest group of Rhesus macaques, the H. pylori status
closely correlated with the CagA status. Next, we com-
pared the percent of macaques positive for both H. pyl-
ori and CagA with those that only were positive for H.
pylori (Table 4). The ratio of double-positive monkeys
increased with age (Figure 1). In total, 36 (40%) of the
89 animals were positive in both assays and 12 (13%)
were only positive for H. pylori.
H. pylori IgG and IgA ODR-values and CagA IgG ODR-
values are higher in older Rhesus macaques
If our analysis is correct and sero-prevalence is truly
higher in older monkeys, ODR-values and monkey age
should be correlated. Linear regression analysis to exam-
ine H. pylori IgG and IgA and CagA IgG values in rela-
tion to monkey age were performed (Figure 2A-C). For
both H. pylori IgG and IgA, there were significant trends
Table 1 H. pylori antibody responses and inflammation scores for the 30 Rhesus macaques of Cohort 1
Evidence for Mean± SDa
H. pylori presence H. pylori CagA Inflammation score
Endoscopy IgG serology n IgG IgA IgG
- - 9 0.13 ± 0.07 0.20 ± 0.12 0.08 ± 0.06 1.25 ± 1.39
- + 4 0.75 ± 0.27 0.66 ± 0.45 0.41 ± 0.24 2.25 ± 0.96
+ + 17 1.10 ± 0.38 0.94 ± 0.53 0.71 ± 0.50 4.56 ± 1.83
a Mean ODR-values were significantly (p < 0.001) different between the known negative (n = 9) and the known positive (n = 17) monkeys for each antibody
response and for inflammation score. Mean values were significantly different between the negative monkeys and the monkeys that were endoscopy negative
but IgG positive (n = 4) for CagA antibody response (p < 0.02) but not for inflammation score.
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obtained for CagA IgG. This remains true after adjusting
for gender in the linear regression analysis. Moreover, H.
pylori IgG levels in female monkeys appear to increase
faster as they age compared with males values. Females
also had elevated H. pylori IgA and CagA IgG levels
compared to males throughout their lifetime (not
shown). There also were significant gender differences in
H. pylori IgG sero-prevalence between females and
males (Odd ratio = 2.56, 95% CI: 1.04-6.32, p = 0.04)
when the total number of monkeys was analyzed. In
summary, older Rhesus macaques have higher H. pylori
IgG and IgA and CagA IgG ODR-values, consistent with
a higher prevalence of H. pylori and of CagA-positive
strains in older monkeys.CagA status of IgA/IgG positive Rhesus macaques
Using a very stringent criterion in which only IgA and IgG
double-positive macaques were considered as H. pylori-
positive (Figure 1), there were 39 (44%) monkeys that were
double-positive. Of these, 26 (67%) were triple-positive
(H. pylori and CagA IgG, and H. pylori IgA).Table 2 Serological responses to H. pylori antigens in
initial and follow-up sera from Cohort 1 Rhesus
macaques in relation to initial H. pylori status
% positive
H. pylori CagA
Timing Status Number of specimens IgG IgAc IgGd
Initial +a 17 100 88 82
- 13 30 23 23
Follow-up +b 28 93 61 61
- 12 0 18 0
a Positive (colonized) defined as detection of H. pylori from culture or
histological examination of gastric antral biopsy.
b Positive (colonized) defined as detection of H. pylori from culture or
histological examination of gastric antral biopsy, or presence of IgG ODR
(>0.34) in the initial specimen. A total of 40 follow-up serum specimens were
available for examination.
c Positive was defined as ODR >0.4; based on Mean+ 2 intervals of SD of
values from reference group of uninfected monkeys.
d Positive was defined as ODR >0.2; based on Mean+ 2 intervals of SD of
values from reference group of uninfected monkeys.C. jejuni sero-prevalence is not associated with increasing
Rhesus macaque age
We also analyzed C. jejuni positivity by using a cut-off value
obtained by both testing 26 human samples of known C.
jejuni status [28], and by using statistical evaluation of Co-
hort 2 values. A total of 59 monkeys (52%) showed serum
IgG against C. jejuni (Figure 3). There was no correlation
between age and infection status (p=0.23). Using stringent
criteria, counting only IgA and IgG double-positive mon-
keys as C. jejuni positive (Figure 3), a total of 31 monkeys
(35%) were thus positive. The IgA and IgG status were not
correlated, and C. jejuni sero-positivity also was not age-
related (Cochran-Armitage Trend Test, p =0.79). There
was no positive or negative association at any age between
H. pylori and C. jejuni IgG status.C. jejuni IgG and IgA ODR-values do not increase with
Rhesus macaque age
As described for H. pylori, using regression analysis, we
determined whether IgG and IgA ODR-values change with
age. In contrast to H. pylori, C. jejuni IgG or IgA values are
not higher in older macaques (Figure 2D-E). When C.
jejuni IgG mean values for each group were analyzed separ-
ately, there was a significant difference (p=0.004) between
groups 1 and 2, but there was no drop for IgA (Figure 2F).
A similar trend has been described in humans [29,30]. The
IgA median stayed constant for the first three groups and
rose in the oldest Rhesus macaques. In contrast to H. pylori
colonization, C. jejuni positivity did not substantially in-
crease with age.Table 3 Summary of threshold cut-off values in groups of
Rhesus macaques of unknown H. pylori status
H. pylori CagA
Antibody IgG IgA IgG
Cut-off from Cohort 1 0.340 0.440 0.200
Negative (0.000-0.299)b 0.344 0.363 0.198
Positive (0.400-1.000)b 0.297 0.362 0.299
Mean Valuea 0.327 (0.340) 0.388 (0.400) 0.232 (0.200)
Standard Deviation 0.024 0.057 0.050
a Values in ( ) describe the actual ODR-cut-off values used to analyze Cohort 2.
b As calculated, for Cohort 2.
Table 4 H. pylori positivity of 89 Rhesus macaques by
agea
Group 1 – Infants (0.5-0.9 years) (n = 27)
IgG + b CagA+ IgG+/CagA+ IgG+/cagA- IgG-/CagA+ IgG-c
Total # 10 6 2 5 4 17
% 37 22 7 16 15 63
Group 2 – Juvenile (1.0-2.9 years) (n = 24)
IgG + b CagA+ IgG+/CagA+ IgG+/cagA- IgG-/CagA+ IgG-c
Total # 13 11 8 2 3 11
% 54 46 33 8 13 46
Group 3 – Young adult (3.0-9.9 years) (n = 21)
IgG + b CagA+ IgG+/CagA+ IgG+/cagA- IgG-/CagA+ IgG-c
Total # 18 16 13 2 3 3
% 86 76 62 10 14 14
Group 4 – Adult (≥10 years) (n = 17)
IgG + b CagA+ IgG+/CagA+ IgG+/cagA- IgG-/CagA+ IgG-c
Total # 16 13 13 3 0 1
% 94 76 76 18 0 6
Total (n = 89)
IgG + b CagA+ IgG+/CagA+ IgG+/cagA- IgG-/CagA+ IgG-
Total # 57 46 36 12 10 32
% 64 52 40 13 11 36
a From the total of 94 Rhesus macaques studied, 5 that were <0.5 years of age
were excluded.
b positive in either the H. pylori or CagA IgG assay.
c negative in both the H. pylori and CagA IgG assays.
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The original habitats of Rhesus macaques range from
Central to Southeast Asia [31]. However, populations of
Rhesus macaques have been living in captivity forFigure 1 H. pylori IgG, IgA, and CagA status of 89 healthy
Rhesus macaques by age. Rates of positivity for H. pylori
colonization and CagA-status, according to five different serological
classifications defining positivity.generations, since they are the most important non-
human primates used for medical and biological re-
search [32-36]. For this study, we analyzed gastric biop-
sies and blood samples from the animal facility at the
Uniformed Services University of the Health Sciences, to
establish reliable cut-off values for detecting H. pylori
antibodies (Cohort 1). To investigate the sero-prevalence
of responses to H. pylori and C. jejuni antigens in social
Rhesus macaques, we studied blood samples routinely
taken from a population of animals living together in
one outdoor cage in the Caribbean Primate Research
Center since 1984 (Cohort 2). We sought to determine
how prevalent H. pylori and C. jejuni-specific antibodies
are in a group of Rhesus macaques to evaluate whether
the colonization rates of monkeys are similar to human
populations.
Although H. pylori and C. jejuni are phylogenetically
close, they differ substantially in the nature of their anti-
gens [37], even including conserved proteins like their
heat-shock protein 60 [38]. Among other factors, flagel-
lae proteins [39], adhesins and outer membrane proteins
differ considerably between C. jejuni and H. pylori [40].
In this study we used water-extracted proteins as anti-
gens. Potential cross-reactions between H. pylori and
Campylobacter antigens have been addressed in previous
studies [41,42] and are considered to be of minor signifi-
cance [43]. Moreover, the immune response to CagA is
specific for H. pylori and no cross-reactions have been
described.
Using the biopsy and blood samples from Cohort 1,
we were able to establish ELISAs that were 100% specific
and 93% sensitive for H. pylori IgG detection, and 100%
sensitive for CagA IgG. In contrast, the IgA ELISA was
much less specific and sensitive and as is the case with
humans [44], not sufficiently accurate for classification
of H. pylori status in Rhesus macaques.
The determined ELISA parameters were used to evalu-
ate Cohort 2 for H. pylori prevalence. In developed
countries, H. pylori is disappearing [1,2] but in develop-
ing countries, H. pylori prevalence remains high [3,4].
The prevalence of H. pylori in monkeys clearly increases
with age. In the oldest monkeys, positivity increased to
94%. Even using a more stringent IgG and IgA double
positive criterion to classify monkeys as H. pylori-colo-
nized, the trends remain the same and the same age-
dependency was observed for the CagA IgG ELISA. Par-
allel age trends are commonly observed in studies con-
ducted in human populations [27,45]. However, in
contrast to humans, younger Rhesus macaques have the
same likelihood to have a CagA-positive strain as do the
macaques in the oldest group. Comparing double- (44%)
and triple- (29%) positive rates, about 67% of the H. pyl-
ori-positive monkeys were colonized with a CagA+ strain.
This is comparable to the situation among humans in
Figure 2 Linear regression analysis of H. pylori and C. jejuni serum antibodies by monkey age. ODR-values for H. pylori IgG and IgA and
CagA IgG (Panels A-C). Outliers (p < 0.001) were excluded from analysis in the H. pylori IgG group (n = 3); R-values and p-values are provided in
each panel. For H. pylori IgG, H. pylori IgA, CagA IgG, N= 89. H. pylori serum antibody levels were positively correlated with age (p < 0.001, in each
case). C. jejuni IgG and IgA ODR-values in relation to monkey age (Panels D-E). C. jejuni IgA and IgG, N = 89; For C. jejuni, older age was not
associated with higher ODR-values (p > 0.05). Analysis of C. jejuni IgG median ODR-values (Panel F). For the box-plot analyses (Median 25–75
percentiles shown, with 10–90 percentile shown as whiskers. Outliers (p < 0.001) were excluded. * p = 0.035.
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ing Rhesus macaques in captivity resemble the pre-
modern situation for H. pylori colonization. One possible
route of acquiring H. pylori in younger monkeys is by
oral-oral contact [46] with older monkeys. Free-living
monkeys and monkeys in captivity have close contact with
each other, making it impossible to trace infection routes
back to parents, siblings, aunts or playmates, without the
ability to genotype the strains. How the Rhesus macaques
originally acquired H. pylori also remains unclear.Genotyping would help to elucidate whether the strains
are of human origin, and whether such strains were intro-
duced into the Rhesus macaque population before or after
they were captured in 1938 and brought to Cayo Santiago
Island (i.e. carrying an Asian strain). Strain isolation from
gastric biopsies and multi-locus sequence typing (MLST)
analysis could help answer these questions.
To determine the cut-off values for the C. jejuni
ELISA, we used blood samples from humans of known
C. jejuni status [28]. The tested 94 monkeys did not
Figure 3 C. jejuni sero-status of 89 healthy Rhesus macaques
by age.
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no evidence of acute infection. In contrast to H. pylori,
there was no correlation between age and C. jejuni sero-
positivity. In general, the prevalence of C. jejuni IgG was
equally high in all the groups, with a significant drop of
prevalence of IgG antibodies in juvenile Rhesus macaques.
However, a high prevalence of C. jejuni IgA was observed
in that group. In areas in which C. jejuni infection is hyper-
endemic and infection is recurrent, young children develop
high levels of specific serum IgG antibodies. With contin-
ued exposure, IgG levels wane and IgA levels rise [29,30],
and the duration of colonization diminishes reflecting de-
velopment of gut immunity [36]. The drop in IgG between
infant and juvenile macaques that we observed is consist-
ent with this phenomenon. As in humans, C. jejuni causes
transient infection in Rhesus macaques and specific anti-
bodies are detected in convalescence [47].
Conclusions
This study describes the distribution of H. pylori and C.
jejuni-specific antibodies in a social group of Rhesus
macaques living in captivity. The study indicates that
Rhesus macaques have widespread exposure to two im-
portant human mucosal bacteria, suggesting that they
may provide a good model to study short- and long-
term effects of C. jejuni and H. pylori colonization, re-
spectively, in a population. The ELISAs that were estab-
lished provide methods to determine the H. pylori




Two cohorts of Rhesus macaques were studied. Cohort
1 consisted of 30 domestic male Rhesus macaques(Macaca mulatta) [2 to 7 years old and weighing 3–
5 kg] from the animal facility at the Uniformed Service
University of the Health Sciences in Bethesda, Maryland.
Samples were collected between January 1988 to May
1995. Upon arrival to the facility, these monkeys had
been quarantined for 90 days in individual stainless steel
cages in conventional holding rooms of the animal facil-
ity [approved by The American Association for Accredit-
ation of Laboratory Animal Care (AALAC)] and were
subsequently kept in similar individual cages. Animals
were provided with tap water ad libitum, commercial
primate chow, and fruit. All subsequent studies were
performed after an overnight fast, between 8 am and
noon.
The studied social group of monkeys (Cohort 2) con-
sisted of 94 Rhesus macaques housed in the Caribbean
Primate Research Center in Sabana Seca, Puerto Rico.
These animals are descendants of monkeys brought to the
Research Center in 1984 from the free-ranging colony on
Cayo Santiago Island. They are co-housed and are in con-
stant contact with one another. Serum samples were col-
lected between December 2008 and April 2010. The
studies were performed in a cross-sectional design for de-
termination of H. pylori and C. jejuni status, according to
age. The Rhesus macaques (Cohort 2, N=94, 60 females,
34 males) were assigned to groups according to age: group
1 (Infant) includes monkeys <1 year [N=32 (17 females/
15 males)]; group 2 (Juvenile) monkeys were 1.0-2.9 years
[N=24(18/6)]; group 3 (Young Adult) monkeys were 3.0-
9.9 years [N=21(12/9)] and group 4 (Adult) consisted of
all monkeys ≥10 years of age [N=17(13/4)]. Of the 32
monkeys in group 1, five (3 female, 2 male) <0.5 years
were excluded from serological analysis, due to potential
maternal antibodies.
Endoscopic procedures and biopsies
The 30 Rhesus macaques of Cohort 1 underwent gastro-
duodenal endoscopic examination under general
anesthesia, essentially as described [13]. From each ani-
mal, six pinch biopsies of the gastric corpus and six from
gastric antral mucosa were obtained. Two biopsies from
each region were fixed in neutral 10% buffered formalin
and embedded in paraffin. Biopsy sections were stained
with haematoxylin and eosin or Genta’s method and
viewed under 100x to 1,000x magnification. The pres-
ence of inflamamatory cells in the biopsies was scored
on coded slides, as described [47]; as were the presence
of stained H. pylori organisms, as described [13]. Two
other biopsies from antrum and corpus were immedi-
ately placed in 0.1 ml sterile 0.9% NaCl on ice and pro-
cessed for H. pylori isolation, as described [47]. H. pylori
isolates were identified as pinhead-colonies, urease-,
oxidase- and catalase-positive, and were Gram-negative
curved or “gull-wing” rods.
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From each Rhesus macaque at the time of each endos-
copy, five milliliters of blood was collected in tubes con-
taining 10.5 mg of EDTA and centrifuged; the supernatant
plasma was frozen at −70°C. The monkey samples were
diluted 1:800 for IgG and 1:100 for IgA. Anti-H. pylori im-
munoglobulin G (IgG) and A (IgA) levels in the plasma
were determined, using a modification of a method with
high sensitivity and specificity for human H. pylori positiv-
ity, as described [13,41]. In brief, the H. pylori antigens,
composed of a mixture of protein and lipopolysaccharides
from five H. pylori strains (ATCC 53722, 53721, 53725,
53726, and 53727), were obtained by water extraction and
sonication, as described [41]. The mixture was diluted in
0.05 M carbonate buffer (pH 9.6) to coat each well of a
flat-bottom ELISA-plate with 1.0 mg antigen. Plates were
coated overnight at 4°C and then blocked for 3 h with 1x
PBS containing 0.05% Tween-20, 0.1 mg/ml thimerosal,
and 0.1% gelatin. Serum samples were added and plates
were incubated for 1 h at 37°C. All washing steps were
performed with 1x PBS containing 0.05% Tween-20 and
0.1 mg/ml thimerosal. Goat anti-monkey IgG (gamma
chain) or IgA (alpha chain) conjugated to horseradish per-
oxidase (Rockland Immunochemicals Inc., Gilbertsville,
PA) was used as second antibody for detection of
responses. A cut-off value was established to distinguish
between positive and negative results in the IgG enzyme-
linked immunosorbent assay (ELISA) by determining
ODR-values (optical density ratio). ODRs were deter-
mined for each sample by dividing the OD-value of the
sample by the OD-value of two positive controls for H.
pylori and C. jejuni IgA and IgG and one positive control
for H. pylori CagA, which were included on each ELISA
plate as reference specimens. Using 9 Rhesus macaques
found to be H. pylori negative by tissue examination
(negative culture or histology), the mean ODR-value plus
3 intervals of standard deviation (SD) from those animals
was used to define the threshold for negativity (0.34). For
IgA, the mean value of 9 uninfected monkeys plus 2 inter-
vals of SD was used to define the threshold for negativity
(0.44). An ELISA to detect anti-CagA IgG in plasma from
the monkeys was performed using a purified recombinant
CagA antigen, as described [48]. The assay was modified
with the use of a goat anti-monkey IgG (gamma chain)
conjugate. The monkey plasma was diluted 1:100. A cut-
off value was established to distinguish between positive
and negative CagA results based on the 9 monkeys found
by tissue exam to be H. pylori-negative. The mean value
plus 2 intervals of SD for the 9 animals was used to define
the threshold for positivity (0.20).
Measurement of H. pylori-specific antibodies in Cohort 2
For cohort 2, ELISAs were performed as described
above. Each sample was tested twice and in the case ofdisparate results, a third measurement was performed. If
samples had discordant ODR-values in the two runs
(values close to the negative and positive controls, re-
spectively), we assumed that at least one value was an
artifact, and the assay repeated. An assay also was
repeated when the ODR-values were close to the thresh-
old values. Resulting ODRs were averaged and evaluated
using the determined cut-off values from the reference
values from Cohort 1. Additionally, Cohort 2 values
were statistically analyzed to evaluate whether the same
cut-off values could be obtained without using the refer-
ence group. To obtain the cut-off for positive samples,
the mean of ODRs between 0.4-1.0 was calculated and 2
times the SD was subtracted, providing a cut-off for
positivity (a summary of all values is provided in Table 3).
To determine the negative cut-off, the mean of ODRs
between 0.000-0.299 was calculated and two times the
SD was added. Values between 0.300-0.399 were only
excluded for the statistical analysis of the cut-off values.
After establishing the cut-off values for positivity and
negativity, ODRs between 0.300-0.399 were assigned
according to these values.
C. jejuni ELISAs
Since antigens from sonicated whole C. jejuni cells did
not yield reliable results for serology (not shown), the
McCoy antigen [49] (from PEN1, 2, and 3 strains), as
described [49,50], was used for IgG and IgA determin-
ation. In brief, C. jejuni cells were harvested in sterile
water, washed twice with water and 0.1 g of wet cells
were suspended in 2.5 ml 0.2 M glycine-hydrochloride
buffer (pH 2.2). Suspensions were stirred at 25°C for
15 min and centrifuged at 11,000 x g for 15 min. The
supernatant was collected and sodium hydroxide was
added to neutralize the suspension. Next, the suspension
was dialyzed against water for 24 h at 4°C and the pro-
tein concentration was determined. ELISA was per-
formed as described for H. pylori. Monkey sera were
diluted 1:200 and goat anti-monkey IgG (gamma chain)
or IgA (alpha chain) conjugated to horseradish peroxid-
ase (Rockland Immunochemicals Inc., Gilbertsville, PA)
(1:2000) was used as the secondary antibody. OD405
values were normalized using a known positive human
control serum (1:200) to compare ODR. Each sample
was tested 2–3 times, as described above.
Determination of cut-off values for C. jejuni IgG ELISAs
To initially determine a range to examine seropositivity,
the mean of sera with ODRs between 0.000-0.299 was
calculated and 2 intervals of SD were added, obtaining
an initial negative cut-off of 0.338. Next, the mean of
ODRs between 0.4-1.0 was calculated and 2 SD intervals
substracted resulting in a positive cut-off of 0.318. We
also used 10 serum samples from C. jejuni-positive
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persons. The calculated negative cut-off was 0.362 and
the positive was 0.418. We calculated the mean value for
these three tentative cut-offs, and established a cut-off of
0.340 as an alternative means to define the thresholds
for positivity and negativity.
Determination of cut-off values for C. jejuni IgA ELISAs
IgA cut-offs were calculated as described for IgG. Since
the negative cut-off was 0.368 and the positive cut-off was
0.326, we used a cut-off of 0.350 to analyze Cohort 2.
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